Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 2/20 | 0.38 |
| ▸ | PARP1 | P09874 | 2/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.38 |
| ▸ | BRD4 | O60885 | 2/20 | 0.38 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.38 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.37 |
| ▸ | IKBKB | O14920 | 1/20 | 0.37 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.35 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32688247 | 0.88 | ACMSD (0.44) | ADORA1IKBKBALDH1A1HPGDKMT2A | |
| SCHEMBL32688271 | 0.86 | ALDH1A1 (0.42) | ALDH1A1HPGDKMT2AHDAC8SMN1; SMN2 | |
| SCHEMBL32688149 | 0.85 | TNKS2 (0.40) | ADORA1IKBKBALDH1A1HPGDKMT2A | |
| SCHEMBL32688014 | 0.85 | ULK1 (0.38) | ADORA1IKBKBALDH1A1HPGDKMT2A | |
| SCHEMBL32688183 | 0.85 | KISS1R (0.45) | MAPK14PARP1ADORA1IKBKBALDH1A1 | |
| SCHEMBL32688221 | 0.85 | SIRT2 (0.46) | KMT2ASMN1; SMN2RXFP1 | |
| SCHEMBL32688318 | 0.83 | ALDH1A1 (0.40) | PARP1BRD4IKBKBTNIKALDH1A1 | |
| SCHEMBL32688358 | 0.83 | PSMD14 (0.43) | ALDH1A1 | |
| SCHEMBL32688132 | 0.82 | CXCR2 (0.36) | ADORA1ALDH1A1HPGDKMT2ASMN1; SMN2 | |
| SCHEMBL32688038 | 0.82 | ACMSD (0.45) | ALDH1A1HPGDKMT2ASMN1; SMN2RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078105-A1 | Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors | ORSOBIO INC (US) | 2026-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078105-A1 | Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors | CPT1B, CBR1, MUSK | MAPK14 4336/4885PARP1 1626/4885ADORA1 1595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.